Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Endocrine Pathology
Published in: Endocrine Pathology 1/2022

01-03-2022 | Pathology

The Next Steps for Endocrine Pathology

Authors: Sylvia L. Asa, Lori A. Erickson, Ozgur Mete

Published in: Endocrine Pathology | Issue 1/2022

Login to get access

Excerpt

Tremendous discoveries made over the last 30 years have advanced our understanding of many important aspects of the genetics, proteomics, prognosis, and therapy of endocrine neoplasia. These form the basis of the 2022 WHO classification of endocrine and neuroendocrine tumors. However, there are still many unanswered questions and many unmet needs for patients. This commentary summarizes some of the questions and challenges for endocrine pathologists to address in the coming 5 years. …
Literature
1.
Kiehl TR, Fischer SE, Ezzat S, Asa SL (2008) Mice lacking the transcription factor Ikaros display behavioral alterations of an anti-depressive phenotype. Exp Neurol 211:107-114.CrossRef
2.
3.
Pelosi G, Bianchi F, Dama E, Metovic J, Barella M, Sonzogni A, Albini A, Papotti M, Gong Y, Vijayvergia N (2021) A Subset of Large Cell Neuroendocrine Carcinomas in the Gastroenteropancreatic Tract May Evolve from Pre-existing Well-Differentiated Neuroendocrine Tumors. Endocr Pathol 32: 396-407. https://​doi.​org/​10.​1007/​s12022-020-09659-6CrossRefPubMed
Metadata
Title
The Next Steps for Endocrine Pathology
Authors
Sylvia L. Asa
Lori A. Erickson
Ozgur Mete
Publication date
01-03-2022
Publisher
Springer US
Published in
Endocrine Pathology / Issue 1/2022
Print ISSN: 1046-3976
Electronic ISSN: 1559-0097
DOI
https://doi.org/10.1007/s12022-022-09711-7

Other articles of this Issue 1/2022

Endocrine Pathology 1/2022 Go to the issue

ReviewPaper

Overview of the 2022 WHO Classification of Familial Endocrine Tumor Syndromes

ReviewPaper

Overview of the 2022 WHO Classification of Pituitary Tumors

ReviewPaper

Overview of the 2022 WHO Classification of Adrenal Cortical Tumors

ReviewPaper

Overview of the 2022 WHO Classification of Thyroid Neoplasms

Letter

From Counting Mitoses to Ki67 Assessment: Technical Pitfalls in the New WHO Classification of Endocrine and Neuroendocrine Tumors

ReviewPaper

Overview of the 2022 WHO Classification of Parathyroid Tumors
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits